Annji Pharmaceutical Co (ROCO:7754) Long-Term Capital Lease Obligation : NT$49.36 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Annji Pharmaceutical Co Long-Term Capital Lease Obligation?

Annji Pharmaceutical Co's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was NT$49.36 Mil.

Annji Pharmaceutical Co's quarterly Long-Term Capital Lease Obligation declined from Dec. 2023 (NT$55.34 Mil) to Jun. 2024 (NT$52.37 Mil) and declined from Jun. 2024 (NT$52.37 Mil) to Dec. 2024 (NT$49.36 Mil).

Annji Pharmaceutical Co's annual Long-Term Capital Lease Obligation increased from Dec. 2022 (NT$0.00 Mil) to Dec. 2023 (NT$55.34 Mil) but then declined from Dec. 2023 (NT$55.34 Mil) to Dec. 2024 (NT$49.36 Mil).

Annji Pharmaceutical Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Annji Pharmaceutical Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Annji Pharmaceutical Co Long-Term Capital Lease Obligation Chart

Annji Pharmaceutical Co Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Long-Term Capital Lease Obligation

55.34

49.36

Annji Pharmaceutical Co Semi-Annual Data
	Dec21	Dec22	Jun23	Dec23	Jun24	Dec24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial			-	-	55.34	52.37	49.36

Annji Pharmaceutical Co (ROCO:7754) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Annji Pharmaceutical Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Annji Pharmaceutical Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Annji Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Annji Pharmaceutical Co Ltd (ROCO:7754) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Zhongxiao E. Raod, 16th Floor-6, No. 508, Sector 7, Nangang Distrist, Taipei, TWN, 115011

Website

https://www.ajpharm.com

Annji Pharmaceutical Co Ltd is an R&D based, clinical-stage new drug company dedicated to the development of first-in-class small molecules focusing on indications with highly unmet needs in the therapeutic areas of neurology, dermatology, and inflammatory disorders, including rare diseases such as idiopathic pulmonary fibrosis and Kennedy's disease, or SBMA (Spinal and bulbar muscular atrophy). Its pipeline products include AJ201, AJ302 and AJ303.

Annji Pharmaceutical Co Headlines

No Headlines